Infinx has acquired Glidian, a leading provider of prior authorization automation, to strengthen its AI-driven revenue cycle management solutions and expand its footprint in the laboratory sector. This strategic move enhances patient access solutions, leveraging Glidian’s expertise to improve efficiency in healthcare operations.

Glidian was founded with the goal of automating prior authorizations and streamlining patient access. Its technology-driven approach aligns with Infinx’s mission to optimize healthcare workflows. By joining forces, the two companies will drive innovation and enhance automation, addressing key challenges in prior authorization.

Jaideep Tandon, CEO of Infinx, highlighted the synergy, stating, "Glidian’s expertise in prior authorization, especially in the laboratory market, complements our solutions. We are excited to welcome the Glidian team and continue advancing patient access and automation."

The acquisition brings together established integrations with nationwide payers, enabling smoother workflows and improved efficiency. The combined entity now processes approximately 700,000 patient access transactions monthly, offering seamless prior authorization services.

Glidian customers will benefit from Infinx’s AI-powered platform, which adapts to payer requirements, improving automation, accuracy, and approval rates. This integration ensures a smarter, faster, and more efficient authorization process.

Ashish Dua, CEO of Glidian, expressed enthusiasm, stating, "Infinx’s innovation and expertise will accelerate our automation efforts, enhancing patient access experiences industry-wide."